Eli Lilly's performance in the biopharmaceutical sector reflects its strong market position, despite facing challenges. The ...
Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback